Needham & Co downgrades Celldex Therapeutics Inc. (Nasdaq: CLDX) from Buy to Hold.

Needham analyst says, "Yesterday after market ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE